Archive for April, 2007

Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers

Human Genome Sciences, Inc. today reported that clinical and preclinical evidence continues to emerge demonstrating that its TRAIL

Ranbaxy receives FDA approval to manufacture and market Pravastatin

Ranbaxy Laboratories Limited (RLL), announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market

Long-Acting Erythropoiesis Stimulating Agent Injection Syringe Receives Approval in Japan

Tokyo, April 25 : Kirin Brewery announced that it received manufacturing and marketing approval for its long-acting erythropoiesis stimulating agent

Adult Stem Cells Give Hawaii’s Favorite Son 15 Months of Standing Ovations

April 21, 2007 : Entertainer Don Ho, a household name in the U.S., who died last week after a long battle with heart failure, gained an extra

Beckman Coulter to Webcast Annual Stockholders’ Meeting

April 20 : Beckman Coulter, Inc. , a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing,

India’s biotech industry emerging as world innovator

Washington, April 10 - India’s health biotech firms are emerging as a major global player, with growing means and know how to produce innovative as well as generic drugs and vaccines at lesser costs compared to giant Western companies.

GlaxoSmithKline signs outsourcing deal with TCS

London, April 2 - GlaxoSmithKline (GSK), Britain’s largest drug company, has signed an outsourcing deal with India’s Tata Consulting Services to establish a drug development support facility in Mumbai.